NCT05066685View on ClinicalTrials.gov

Characteristics of Patients With Neovascular Age-related Macular Degeneration Enrolled in the Brolucizumab Patient Support Services Program

CompletedOBSERVATIONAL
Enrollment

18,457

Participants

Timeline

Start Date

August 11, 2020

Primary Completion Date

September 25, 2020

Study Completion Date

September 25, 2020

Conditions
Age-related Macular Degeneration (AMD)
Interventions
OTHER

All participants

All the particpants enrolled in the brolucizumab Patient Support Services (PSS) program

Trial Locations (1)

07936-1080

Novartis Investigative Site, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY